Clinical Trials & Results

Find a Trial or Results of a Completed Trial

Filter

Health Condition

Toggle

Study Status

Toggle

Age group

Toggle

Gender

Toggle

Phase

Toggle

Study Types

Toggle

Showing 20 of 30 Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Study ID: 116B8 | 2009-010562-31

inflammation and infections icon for clinical trials
Condition(s):
Stable Renal Transplant Recipients
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)

Study ID: 9013

neurology icon for clinical trials
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 50 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Betaseron | Drug: Rebif

Study ID: ABS-AS-306

Condition(s):
Asthma
Status:
Terminated
Requirements:
12 Years and older
Interventions:
Drug: Placebo Spiromax | Drug: Albuterol Spiromax

Study ID: ALS-TAL-201-OL

neurology icon for clinical trials
Condition(s):
Amyotrophic Lateral Sclerosis
Status:
Terminated
Requirements:
18 Years to 80 Years
Interventions:
Drug: Talampanel

Study ID: C38072/3085 | 2010-024540-15

Condition(s):
Eosinophilic Asthma
Status:
Terminated
Requirements:
12 Years to 75 Years
Interventions:
Drug: Reslizumab

Study ID: C38072-AS-30066 | 2016-004661-23

Condition(s):
Eosinophils, Asthma
Status:
Terminated
Requirements:
12 Years and older
Interventions:
Drug: reslizumab

Study ID: C38072-AS-40105

Condition(s):
Asthma
Status:
Terminated
Requirements:
18 Years to 50 Years
Interventions:
Drug: Reslizumab | Drug: Fludeoxyglucose F 18 (FDG) | Drug: Placebo

Study ID: C41443/2057 | 2013-005320-42

cancer icon for clinical trials
Condition(s):
Chronic Myeloid Leukemia
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: Omacetaxine mepesuccinate

Study ID: GA-MS-302 | 2011-005550-57

neurology icon for clinical trials
Condition(s):
Relapsing-Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 55 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Placebo

Study ID: IXR-205-21-189

cancer icon for clinical trials
Condition(s):
Glioblastoma Multiforme | Anaplastic Astrocytoma|Anaplastic Oligodendroglioma | Anaplastic Mixed Oligoastrocytoma
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: Talampanel

Study ID: IXR-402-4-196

Condition(s):
Asthma
Status:
Terminated
Requirements:
12 Years to 70 Years
Interventions:
Drug: Qvar | Drug: Flovent Diskus

Study ID: LAQ/5063OL | LAQ/5063 | 2005-004334-41

neurology icon for clinical trials
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 50 Years
Interventions:
Drug: Laquinimod | Drug: Placebo

Study ID: MS-LAQ-301E | 2009-012989-30

neurology icon for clinical trials
Condition(s):
Relapsing Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 55 Years
Interventions:
Drug: Laquinimod

Study ID: MS-LAQ-302E | 2009-015815-42

neurology icon for clinical trials
Condition(s):
Relapsing Multiple Sclerosis
Status:
Terminated
Requirements:
Child, Adult, Older Adult
Interventions:
Drug: Laquinimod

Study ID: TAL-MB-100

disease icon for clinical trials
Condition(s):
Healthy
Status:
Terminated
Requirements:
18 Years to 55 Years
Interventions:
Drug: Talampanel (non-radiolabeled), [14C] Talampanel

Study ID: TNC GA MS 2004_01

neurology icon for clinical trials
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 55 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone

Study ID: TV1106-IMM-20001 | 2013-004468-69

muscle icon for clinical trials
Condition(s):
Growth Hormone-Deficiency
Status:
Terminated
Requirements:
3 Years to 11 Years
Interventions:
Drug: TV-1106 | Drug: somatropin

Study ID: TV1106-IMM-30021 | 2014-003796-32

muscle icon for clinical trials
Condition(s):
Growth Hormone Deficiency
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: TV-1106 | Drug: Placebo

Study ID: TV1106-IMM-30022 | 2014-002736-13

muscle icon for clinical trials
Condition(s):
Growth Hormone Deficiency
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: TV-1106 | Drug: dGH

Study ID: TV44688-ONC-30054

disease icon for clinical trials
Condition(s):
Healthy Participants
Status:
Terminated
Requirements:
18 Years to 60 Years
Interventions:
Drug: Tbo-filgrastim